Cargando…

Progress in fed-batch culture for recombinant protein production in CHO cells

ABSTRACT: Nearly 80% of the approved human therapeutic antibodies are produced by Chinese Hamster Ovary (CHO) cells. To achieve better cell growth and high-yield recombinant protein, fed-batch culture is typically used for recombinant protein production in CHO cells. According to the demand of nutri...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wen-Jing, Lin, Yan, Mi, Chun-Liu, Pang, Jing-Ying, Wang, Tian-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843118/
https://www.ncbi.nlm.nih.gov/pubmed/36648523
http://dx.doi.org/10.1007/s00253-022-12342-x
_version_ 1784870314141810688
author Xu, Wen-Jing
Lin, Yan
Mi, Chun-Liu
Pang, Jing-Ying
Wang, Tian-Yun
author_facet Xu, Wen-Jing
Lin, Yan
Mi, Chun-Liu
Pang, Jing-Ying
Wang, Tian-Yun
author_sort Xu, Wen-Jing
collection PubMed
description ABSTRACT: Nearly 80% of the approved human therapeutic antibodies are produced by Chinese Hamster Ovary (CHO) cells. To achieve better cell growth and high-yield recombinant protein, fed-batch culture is typically used for recombinant protein production in CHO cells. According to the demand of nutrients consumption, feed medium containing multiple components in cell culture can affect the characteristics of cell growth and improve the yield and quality of recombinant protein. Fed-batch optimization should have a connection with comprehensive factors such as culture environmental parameters, feed composition, and feeding strategy. At present, process intensification (PI) is explored to maintain production flexible and meet forthcoming demands of biotherapeutics process. Here, CHO cell culture, feed composition in fed-batch culture, fed-batch culture environmental parameters, feeding strategies, metabolic byproducts in fed-batch culture, chemostat cultivation, and the intensified fed-batch are reviewed. KEY POINTS: • Fed-batch culture in CHO cells is reviewed. • Fed-batch has become a common technology for recombinant protein production. • Fed batch culture promotes recombinant protein production in CHO cells.
format Online
Article
Text
id pubmed-9843118
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98431182023-01-17 Progress in fed-batch culture for recombinant protein production in CHO cells Xu, Wen-Jing Lin, Yan Mi, Chun-Liu Pang, Jing-Ying Wang, Tian-Yun Appl Microbiol Biotechnol Mini-Review ABSTRACT: Nearly 80% of the approved human therapeutic antibodies are produced by Chinese Hamster Ovary (CHO) cells. To achieve better cell growth and high-yield recombinant protein, fed-batch culture is typically used for recombinant protein production in CHO cells. According to the demand of nutrients consumption, feed medium containing multiple components in cell culture can affect the characteristics of cell growth and improve the yield and quality of recombinant protein. Fed-batch optimization should have a connection with comprehensive factors such as culture environmental parameters, feed composition, and feeding strategy. At present, process intensification (PI) is explored to maintain production flexible and meet forthcoming demands of biotherapeutics process. Here, CHO cell culture, feed composition in fed-batch culture, fed-batch culture environmental parameters, feeding strategies, metabolic byproducts in fed-batch culture, chemostat cultivation, and the intensified fed-batch are reviewed. KEY POINTS: • Fed-batch culture in CHO cells is reviewed. • Fed-batch has become a common technology for recombinant protein production. • Fed batch culture promotes recombinant protein production in CHO cells. Springer Berlin Heidelberg 2023-01-17 2023 /pmc/articles/PMC9843118/ /pubmed/36648523 http://dx.doi.org/10.1007/s00253-022-12342-x Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Mini-Review
Xu, Wen-Jing
Lin, Yan
Mi, Chun-Liu
Pang, Jing-Ying
Wang, Tian-Yun
Progress in fed-batch culture for recombinant protein production in CHO cells
title Progress in fed-batch culture for recombinant protein production in CHO cells
title_full Progress in fed-batch culture for recombinant protein production in CHO cells
title_fullStr Progress in fed-batch culture for recombinant protein production in CHO cells
title_full_unstemmed Progress in fed-batch culture for recombinant protein production in CHO cells
title_short Progress in fed-batch culture for recombinant protein production in CHO cells
title_sort progress in fed-batch culture for recombinant protein production in cho cells
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843118/
https://www.ncbi.nlm.nih.gov/pubmed/36648523
http://dx.doi.org/10.1007/s00253-022-12342-x
work_keys_str_mv AT xuwenjing progressinfedbatchcultureforrecombinantproteinproductioninchocells
AT linyan progressinfedbatchcultureforrecombinantproteinproductioninchocells
AT michunliu progressinfedbatchcultureforrecombinantproteinproductioninchocells
AT pangjingying progressinfedbatchcultureforrecombinantproteinproductioninchocells
AT wangtianyun progressinfedbatchcultureforrecombinantproteinproductioninchocells